HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

945.210

+18.3191.98%

Number of Gainers:6

Number of Losers:4

Number of Flat:3

PE:- -

High:960.788

Open:927.655

Low:919.699

Close:926.891

Loading ...

BRIEF-Miricor Enterprises Says Expected Net Profit Of At Least HK$10 Million For FY2025

Miricor Enterprises Holdings Ltd. Issues Positive Profit Forecast for Fiscal Year Ending March 2025

Miricor Enterprises Holdings Ltd - Profit Due to Operational Efficiency and Cost Control

THOMSON REUTERS

Miricor Enterprises - Expected FY Net Profit of at Least HK$10 Mln for FY2025

THOMSON REUTERS

Sihuan Pharmaceutical Holdings Group Ltd. Conducted Annual General Meeting

Modern Dental Group Ltd. Files Next Day Disclosure to HKEX Announcing Repurchase of 100,000 Shares at HKD 414,940 Total

Fosun Pharma's Respiratory Drug Receives Clinical Trial Approval for COPD Treatment in China

MT Newswires Live

Raily Aesthetic Medicine International Holdings Ltd. Conducted Annual General Meeting

Fosun Pharmaceutical Gets Chinese Regulatory Approval for Breast Cancer Drug; Shares Up 4%

MT Newswires Live

Modern Dental Group Ltd. Conducted Annual General Meeting

Fosun Pharmaceutical Gains EU Orphan Drug Status for Cancer Drug

MT Newswires Live

Angelalign Technology Inc. Conducted Annual General Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":945.21027,"timestamp":1749197315277,"preClose":926.8911,"halted":0,"volume":190166883,"delay":0,"changeRate":0.019764,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":18.319153,"latestTime":"06-06 16:00:00","open":927.65546,"high":960.78827,"low":919.6992,"amount":1688958652,"amplitude":0.04433,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749432600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"pbRate":1.475053,"peRate":22.374308,"turnoverRate":0.009277,"increases":5,"decrements":4,"flats":4,"marketCap":154564515600,"floatMarketCap":114333026128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":960.78827,"amplitude":0.04433,"preClose":926.8911,"low":919.6992,"pbRate":"1.475053","latestPrice":945.21027,"volume":190166883,"delay":0,"open":927.65546,"prevYearClose":571.87146,"prevWeekClose":913.531,"prevMonthClose":913.531,"prevQuarterClose":677.607,"fiveDayClose":913.531,"twentyDayClose":693.979,"sixtyDayClose":615.91,"secType":"PLATE","market":"HK","turnoverRate":0.009277,"peRate":22.374308,"marketCap":154564515600,"floatMarketCap":114333026128,"timestamp":1749197315277,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":6,"down":4,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541988852","title":"BRIEF-Miricor Enterprises Says Expected Net Profit Of At Least HK$10 Million For FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2541988852","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541988852?lang=en_us&edition=fundamental","pubTime":"2025-06-06 19:55","pubTimestamp":1749210950,"startTime":"0","endTime":"0","summary":"BRIEF-Miricor Enterprises Says Expected Net Profit Of At Least HK$10 Million For FY2025June 6  - Miricor Enterprises Holdings Ltd 1827.HK:EXPECTED FY NET PROFIT OF AT LEAST HK$10 MILLION FOR FY2025PROFIT DUE TO OPERATIONAL EFFICIENCY AND COST CONTROLFurther company coverage: 1827.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nFWN3S80OZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1215","01827"],"gpt_icon":0},{"id":"2541485413","title":"Miricor Enterprises Holdings Ltd. Issues Positive Profit Forecast for Fiscal Year Ending March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2541485413","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541485413?lang=en_us&edition=fundamental","pubTime":"2025-06-06 19:29","pubTimestamp":1749209399,"startTime":"0","endTime":"0","summary":"Miricor Enterprises Holdings Ltd. has issued a positive profit alert, indicating that the company anticipates improved financial performance for the year ending March 31, 2025. This forecast is based on a preliminary assessment of the company's management accounts, which have yet to be audited or reviewed by the company's auditor or audit committee. The actual financial results, which will be disclosed in the audited consolidated financial statements, might vary. The company has advised shareholders and potential investors to exercise caution when dealing with its shares, as the final results will be detailed in an upcoming annual results announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Miricor Enterprises Holdings Ltd. pub","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL3J2VW0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01827","BK1215","BK1593"],"gpt_icon":0},{"id":"2541678854","title":"Miricor Enterprises Holdings Ltd - Profit Due to Operational Efficiency and Cost Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2541678854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541678854?lang=en_us&edition=fundamental","pubTime":"2025-06-06 19:25","pubTimestamp":1749209145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nFWN3S80OZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1215","01827","BK1593"],"gpt_icon":0},{"id":"2541545718","title":"Miricor Enterprises - Expected FY Net Profit of at Least HK$10 Mln for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2541545718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541545718?lang=en_us&edition=fundamental","pubTime":"2025-06-06 19:25","pubTimestamp":1749209145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nFWN3S80OZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01827","BK1593","BK1215"],"gpt_icon":0},{"id":"2541859863","title":"Sihuan Pharmaceutical Holdings Group Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541859863","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541859863?lang=en_us&edition=fundamental","pubTime":"2025-06-06 18:28","pubTimestamp":1749205692,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. held its annual general meeting on 6 June 2025. During the meeting, several proposals were approved. These included the adoption of the audited consolidated financial statements for the year ended 31 December 2024, the re-election of retiring directors, and the extension of authority to the directors to issue shares and manage treasury shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief on June 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL2258tp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","BK1191","00460","BK1593"],"gpt_icon":0},{"id":"2541028837","title":"Modern Dental Group Ltd. Files Next Day Disclosure to HKEX Announcing Repurchase of 100,000 Shares at HKD 414,940 Total","url":"https://stock-news.laohu8.com/highlight/detail?id=2541028837","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541028837?lang=en_us&edition=fundamental","pubTime":"2025-06-06 17:14","pubTimestamp":1749201266,"startTime":"0","endTime":"0","summary":"Modern Dental Group Ltd., incorporated in the Cayman Islands, has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange. The company disclosed the repurchase of 600,000 shares at a total aggregate price of HKD 414,940. The transaction is part of a repurchase mandate authorized on May 29, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Dental Group Ltd. published the original content used to generate this news brief on June 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL2Y3Yk8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03600","BK1583","BK1100","BK1593"],"gpt_icon":0},{"id":"2540673807","title":"Fosun Pharma's Respiratory Drug Receives Clinical Trial Approval for COPD Treatment in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2540673807","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540673807?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:07","pubTimestamp":1748862470,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical  Co.'s  independently developed small molecule oral DPP-1 inhibitor, XH-S004, has been approved for clinical trials in China for the treatment of chronic obstructive pulmonary disease .XH-S004 is also being trialed for the treatment of non-cystic fibrosis bronchiectasis, according to its Hong Kong bourse filing on Friday.As of April, the Group had invested about 61 million yuan in the research and development of XH-S004.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","02196","00656","BK1230","BK1515","BK1593"],"gpt_icon":0},{"id":"2539267262","title":"Raily Aesthetic Medicine International Holdings Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2539267262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539267262?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:53","pubTimestamp":1748602412,"startTime":"0","endTime":"0","summary":"Raily Aesthetic Medicine International Holdings Ltd. held its 2025 annual general meeting on 30 May 2025. All proposed resolutions were approved by shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Raily Aesthetic Medicine International Holdings Ltd. published the original content used to generate this news brief on May 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL3MXnL0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2539219128","title":"Fosun Pharmaceutical Gets Chinese Regulatory Approval for Breast Cancer Drug; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539219128","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539219128?lang=en_us&edition=fundamental","pubTime":"2025-05-30 11:19","pubTimestamp":1748575161,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical  subsidiary Jinzhou Aohong Pharmaceutical received the approval of China's drug administrator for its citrate-formulated novel drug FCN-437c in capsule form, according to a Thursday filing with the Shanghai bourse.The approved indication is in combination with fulvestrant for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer following prior endocrine therapy.Shares of the pharmaceutical company rose 4% in recent trade on the Shanghai bourse.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0096","600196","BK0239","BK0187","BK0183","BK0196","BK0175","BK1515","BK1593","BK1230","BK0188","02196","BK0028","BK0060","BK1191","BK0012","00656"],"gpt_icon":0},{"id":"2539509422","title":"Modern Dental Group Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2539509422","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539509422?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:17","pubTimestamp":1748521068,"startTime":"0","endTime":"0","summary":"Modern Dental Group Ltd. held its Annual General Meeting on May 29, 2025. The meeting saw the approval of several proposals. The audited consolidated financial statements and the reports of the directors and auditors for the year ended December 31, 2024, were received and considered. A final dividend out of the share premium account was declared. Ms. Chan Yik Yu was re-elected as an executive director, and Mr. Chan Chi Yuen was also re-elected as an executive director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Dental Group Ltd. published the original content used to generate this news brief on May 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL2T9XPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03600","BK1583","BK1593","BK1100"],"gpt_icon":0},{"id":"2538243520","title":"Fosun Pharmaceutical Gains EU Orphan Drug Status for Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2538243520","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538243520?lang=en_us&edition=fundamental","pubTime":"2025-05-27 12:42","pubTimestamp":1748320947,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) said its anti-HER2 drug HLX22 was granted orphan drug designation by the European Commission.The drug is used for gastric and breast cancer treatment.Further clinical trials and regulatory approvals are required before commercialization.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1593","BK4156","BK0175","BK0188","BK0239","BK0183","600196","BK0060","00656","BK0028","02196","BK0012","BK0187","BK1515","BK0096","BK0196"],"gpt_icon":0},{"id":"2537417138","title":"Angelalign Technology Inc. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2537417138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537417138?lang=en_us&edition=fundamental","pubTime":"2025-05-23 18:51","pubTimestamp":1747997490,"startTime":"0","endTime":"0","summary":"Angelalign Technology Inc. held its Annual General Meeting on May 23, 2025. The meeting covered several proposals, including the receipt and consideration of the audited financial statements and the reports of directors and the auditor for the year ended December 31, 2024. All proposals presented were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Angelalign Technology Inc. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL2D24LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1593","BK1100","BK1583","06699"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}